Intranasal administration of adrenocorticotropin-(1-24) stimulates adrenocortical hormone secretion

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1750-1753

  Hiroi, Naoki ^a,b,c   Ichijo, Takamasa ^a,b   Ueshiba, Hajime ^a,c   Miyachi, Yukitaka ^a,c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTEROID; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; SODIUM CHLORIDE; TETRACOSACTIDE;

ADRENAL FUNCTION; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CORTICOTROPIN DEFICIENCY; DRUG ABSORPTION; DRUG EFFICACY; ENDOCRINE FUNCTION TEST; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RHINITIS; SIDE EFFECT;

ADMINISTRATION, INTRANASAL; ADRENOCORTICOTROPIC HORMONE; ADULT; ALDOSTERONE; COSYNTROPIN; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; MALE; PEPTIDE FRAGMENTS; REFERENCE VALUES;

EID: 0036277799     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.4.1750     Document Type: Article

References (26)

1. Reduction of atheroscrelosis by administration of DHEA
2. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice
3. Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat
4. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo
5. Dehydroepiandrosterone in synthesis lupus erythematosus. Results of double-blind, placebo-controlled, randomized clinical trial
6. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs
7. Dehydroepiandrosterone replacement in aging human
8. Replacement of DHEA in aging men and woman. Potential remedial effect
9. Corticotropic action of an intra-nasally applied synthetic ACTH derivative
10. Pernasal application of a potent synthetic ACTH 1-17 analogue: Dynamics of cortisol and aldosterone levels before and after 7 days of administration
11. Serum profiles of steroid hormones in patients with Cushing's syndrome determined by a new HPLC/RIA method
12. Effect of formulation additives upon the intranasal bioavailabillty of a peptide drug: Tetracosactide (ACTH1-24)
13. Evidence for existence of cortical androgen-stimulating hormone
14. Intraadrenal mechanisms of DHEA regulation: A hypothesis for adrenopause
15. Discordance of plasma DHEA-S, DHEA, and cortisol responses with various ACTH regimens
16. Role of ACTH in the secretion of free dehydroepiandrosterone and its sulfate ester in man
17. Plasma DHEA-S in normal and pathologic conditions
18. Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: Efficacy vs subcutaneous injections and local tolerance
19. The proopiomelanocortin system
20. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
21. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training
22. Corticotropin-releasing hormone in depression and post-traumatic stress disorder
23. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
24. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
25. Brain potentials and attention after acute and subchronic intranasal administration of ACTH 4-10 and desacetyl-α-MSH in humans
26. A Dehydroepiandrosterone-a neurosteroid